Savonix, Inc. is distinguished as the sole provider of a digital neuropsychology platform with its slogan, "Your virtual neuropsychology platform." Founded in 2015 and headquartered in the United States, Savonix operates at the nexus of various industries, including AI, Health Care, IT, Information Technology, Mobile, and Human Resources.
The company's cloud-based platform is clinically validated and empowers consumers—patients, providers, payers, and researchers—to efficiently screen for cognitive health from mobile devices. This solution is particularly pivotal in the fight against dementia, addressing an ever-expanding global health priority.
The last known investment in Savonix was a Non Equity Assistance investment by StartUp Health on 30 March 2019. This endorsement underscores the potential scalability and social impact of Savonix's offerings within the healthcare ecosystem.